Alliance Pharma Competitors and Similar CompaniesClear all

Alliance Pharma's competitors and similar companies include Merz North America, Servier, Aurobindo Pharma and Glenmark Pharmaceuticals.

	Alliance Pharma Alliance is an international pharmaceutical company.	Merz North America Merz North America is a specialty healthcare company dedicated to the development and marketing of products for physicians and patients.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 1996	Founding Date 1908	Founding Date 1954	Founding Date 1986	Founding Date 1977
Type	Type Private	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Wiltshire, GB HQ Paris, FR Düsseldorf, DE Milano, IT Singapore, SG Tres Cantos, ES see more	Locations Frankfurt am Main, DE HQ Raleigh, US	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 290	Employees 2,4801% increase	Employees 12,9983% increase	Employees 26,015	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) £178.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) ₹131.5b (FY, 2025)
Cost of goods	Cost of goods £68.2m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹134.9b (FY, 2026)	Cost of goods ₹46.7b (FY, 2025)
Gross profit	Gross profit £110.6m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit ₹206.6b (FY, 2026)	Gross profit ₹87b (FY, 2025)
Net income	Net income (£10.7m) (FY, 2024)	Net income N/A	Net income N/A	Net income ₹35b (FY, 2026)	Net income ₹10.5b (FY, 2025)